WILLIAM JAMES POLVINO, M.D.
Osteopathic Medicine at Churchhill Downs Dr, Tinton Falls, NJ
License number
New Jersey 25MA05697700
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
10 Churchhill Downs Dr, Tinton Falls, NJ 07724
Phone
(732) 389-1590
Personal information
See more information about WILLIAM JAMES POLVINO at radaris.comName
Address
Phone
19 Sherwood Ln, Colts Neck, NJ 07722
Eatontown, NJ
10 Churchhill Downs Dr, Eatontown, NJ 07724
3306 Pinhorn Dr, Bridgewater, NJ 08807
70 Valley Brook Rd, Long Valley, NJ 07853
Professional information
Dr. William J Polvino, Tinton Falls NJ - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
10 Churchhill Downs Dr, Tinton Falls 07724
(732) 389-1590 (Phone)
(732) 389-1590 (Phone)
Certifications:
Internal Medicine, 1990
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Medicine And Dentistry of New Jersey / Robert Wood Johnson Medical School
Graduated: 1987
Massachusetts General Hospital
Natl Inst Hlth
University of Medicine And Dentistry of New Jersey / Robert Wood Johnson Medical School
Graduated: 1987
Massachusetts General Hospital
Natl Inst Hlth
Method Of Stimulating The Motility Of The Gastrointestinal System Using Growth Hormone Secretagogues
US Patent:
2007019, Aug 16, 2007
Filed:
Aug 12, 2005
Appl. No.:
11/203639
Inventors:
William Polvino - Tinton Falls NJ, US
International Classification:
A61K 38/04
US Classification:
514019000
Abstract:
The present invention relates to a method of stimulating the motility of the gastrointestinal system in a subject in need thereof, wherein the subject suffers from maladies (i.e., disorders or diseases) of the gastrointestinal system. The method comprises administering to a subject in need thereof a therapeutically effective amount of a growth hormone secretagogue compound or a pharmaceutically acceptable salt, hydrate or solvate thereof. The growth hormone secretagogue can be co-administered with a laxative, a Hreceptor antagonist, a serotonin 5-HTagonist, an antacid, an opioid antagonist, a proton pump inhibitor, a motilin receptor agonist, dopamine antagonist, a cholinergic agonist, a cholinesterase inhibitor, somatostatin, octreotide, or any combination thereof.
Method Of Stimulating The Motility Of The Gastrointestinal System Using Ipamorelin
US Patent:
2012001, Jan 12, 2012
Filed:
Sep 16, 2011
Appl. No.:
13/234248
Inventors:
William J. Polvino - Tinton Falls NJ, US
Richard Nelson - Morristown NJ, US
William R. Mann - Sparta NJ, US
Richard Nelson - Morristown NJ, US
William R. Mann - Sparta NJ, US
Assignee:
HELSINN THERAPEUTICS (U.S.), INC. - Bridgewater NJ
International Classification:
A61K 38/08, A61P 1/02
US Classification:
514 218
Abstract:
The present invention provides a method of stimulating the motility of the gastrointestinal system in a subject in need thereof, wherein the subject suffers from maladies (i.e., disorders, diseases, conditions, or drug- or surgery-induced dysfunction) of the gastrointestinal system, by administering to the subject a ghrelin mimetic, or pharmaceutically acceptable salt thereof. The invention also provides a method of treating a gastrointestinal malady by co-administering a ghrelin mimetic with a laxative, a Hreceptor antagonist, a serotonin receptor agonist, pure or mixed, an antacid, an opioid antagonist, a proton pump inhibitor, a motilin receptor agonist, dopamine antagonist, a cholinergic agonist, a cholinesterase inhibitor, somatostatin, octreotide, or any combination thereof.
Method Of Stimulating The Motility Of The Gastrointestinal System Using Growth Hormone Secretagogues
US Patent:
2012007, Mar 29, 2012
Filed:
Sep 16, 2011
Appl. No.:
13/234387
Inventors:
William J. Polvino - Tinton Falls NJ, US
Assignee:
HELSINN THERAPEUTICS (U.S.), INC. - Bridgewater NJ
International Classification:
A61K 38/27, A61P 1/00
US Classification:
514 113
Abstract:
The present invention relates to a method of stimulating the motility of the gastrointestinal system in a subject in need thereof, wherein the subject suffers from maladies (i.e., disorders or diseases) of the gastrointestinal system. The method comprises administering to a subject in need thereof a therapeutically effective amount of a growth hormone secretagogue compound or a pharmaceutically acceptable salt, hydrate or solvate thereof. The growth hormone secretagogue can be co-administered with a laxative, a Hreceptor antagonist, a serotonin 5-HTagonist, an antacid, an opioid antagonist, a proton pump inhibitor, a motilin receptor agonist, dopamine antagonist, a cholinergic agonist, a cholinesterase inhibitor, somatostatin, octreotide, or any combination thereof.
Method Of Stimulating The Motility Of The Gastrointestinal System Using Ipamorelin
US Patent:
8039456, Oct 18, 2011
Filed:
Nov 26, 2008
Appl. No.:
12/313956
Inventors:
William J. Polvino - Tinton Falls NJ, US
Richard Nelson - Morristown NJ, US
William R. Mann - Sparta NJ, US
Richard Nelson - Morristown NJ, US
William R. Mann - Sparta NJ, US
Assignee:
Helsinn Therapeutics (U.S.), Inc. - Bridgewater NJ
International Classification:
A61K 31/33
US Classification:
514183
Abstract:
The present invention provides a method of stimulating the motility of the gastrointestinal system in a subject in need thereof, wherein the subject suffers from maladies (i. e. , disorders, diseases, conditions, or drug- or surgery-induced dysfunction) of the gastrointestinal system, by administering to the subject a ghrelin mimetic, or pharmaceutically acceptable salt thereof. The invention also provides a method of treating a gastrointestinal malady by co-administering a ghrelin mimetic with a laxative, a Hreceptor antagonist, a serotonin receptor agonist, pure or mixed, an antacid, an opioid antagonist, a proton pump inhibitor, a motilin receptor agonist, dopamine antagonist, a cholinergic agonist, a cholinesterase inhibitor, somatostatin, octreotide, or any combination thereof.
Method Of Stimulating The Motility Of The Gastrointestinal System Using Growth Hormone Secretagogues
US Patent:
8039457, Oct 18, 2011
Filed:
Dec 4, 2009
Appl. No.:
12/631490
Inventors:
William J. Polvino - Tinton Falls NJ, US
Assignee:
Helsinn Therapeutics (U.S.), Inc. - Bridgewater NJ
International Classification:
A61K 31/33
US Classification:
514183
Abstract:
The present invention relates to a method of stimulating the motility of the gastrointestinal system in a subject in need thereof, wherein the subject suffers from maladies (i. e. , disorders or diseases) of the gastrointestinal system. The method comprises administering to a subject in need thereof a therapeutically effective amount of a growth hormone secretagogue compound or a pharmaceutically acceptable salt, hydrate or solvate thereof. The growth hormone secretagogue can be co-administered with a laxative, a Hreceptor antagonist, a serotonin 5-HTagonist, an antacid, an opioid antagonist, a proton pump inhibitor, a motilin receptor agonist, dopamine antagonist, a cholinergic agonist, a cholinesterase inhibitor, somatostatin, octreotide, or any combination thereof.
Method Of Treating Cell Proliferative Disorders Using Growth Hormone Secretagogues
US Patent:
2008020, Aug 28, 2008
Filed:
Feb 11, 2008
Appl. No.:
12/069533
Inventors:
William J. Polvino - Tinton Falls NJ, US
Assignee:
Sapphire Therapeutics - Bridgewater NJ
International Classification:
A61K 31/495, A61K 31/454, A61K 31/4535, A61K 31/45, A61K 31/4468, A61K 31/445, A61K 31/4178, A61K 31/404, A61K 31/437, A61K 31/438, A61P 35/00
US Classification:
51425501, 514323, 514327, 514319, 514330, 514326, 514397, 514400, 514419, 514303, 514278
Abstract:
The present invention relates to a method of treating cell proliferative disorders by administering to a subject an effective amount of a growth hormone secretagogue compound or a pharmaceutically acceptable salt, hydrate or solvate thereof.
Enhanced Migraine Treatments Based On Ghrelin Mimetics
US Patent:
2013028, Oct 31, 2013
Filed:
Jun 18, 2013
Appl. No.:
13/920863
Inventors:
William J. Polvino - Tinton Falls NJ, US
Assignee:
Helsinn Therapeutics (U.S.), Inc. - Bridgewater NJ
International Classification:
A61K 31/454, A61K 31/4045, A61K 45/06
US Classification:
514323
Abstract:
The present invention relates to method of enhancing the absorption of migraine medications and thereby treating migraines by co-administering to a subject in need thereof an effective amount of a ghrelin mimetic or pharmaceutically acceptable salt, hydrate or solvate thereof and at least one migraine medication selected from a serotonin 5-HTreceptor agonist, a tryptamine derivative, an ergoline derivative, a non-steroidal anti-inflammatory drug, or an analgesic, or any combination thereof.
Methods Of Treating Emesis Using Growth Hormone Secretagogues
US Patent:
8394833, Mar 12, 2013
Filed:
May 21, 2012
Appl. No.:
13/476111
Inventors:
William R. Mann - Sparta NJ, US
William J. Polvino - Tinton Falls NJ, US
William J. Polvino - Tinton Falls NJ, US
Assignee:
Helsinn Therapeutics (U.S.), Inc. - Bridgewater NJ
International Classification:
A61K 31/454
US Classification:
514323
Abstract:
The present invention relates to methods of treating emesis by administering to the subject an effective amount of a growth hormone secretagogue compound or a pharmaceutically acceptable salt thereof.
Methods Of Treating Emesis Using Growth Hormone Secretagogues
US Patent:
8288427, Oct 16, 2012
Filed:
Apr 10, 2008
Appl. No.:
12/082411
Inventors:
William R. Mann - Sparta NJ, US
William J. Polvino - Tinton Falls NJ, US
William J. Polvino - Tinton Falls NJ, US
Assignee:
Helsinn Therapeutics (U.S.), Inc. - Bridgewater NJ
International Classification:
A61K 31/4164
US Classification:
514400
Abstract:
A method of treating emesis with growth hormone secretagogues, particularly ipamorelin.